Here in the media centre you will find a range of resources including our latest and archived press releases, statements from our CEO, speeches and presentations, information on our social media policy, and our photo and video library.
A selection of videos and publications featuring our CEO Sir Andrew Witty.
Find the latest and archived speeches and presentations from GSK’s senior executives.
GSK and Theravance announce positive results from pivotal phase III study for fluticasone furoate/vilanterol in asthma
GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from a phase III efficacy and safety study of fluticasone furoate “FF”/vilanterol “VI”.
A GSK research paper published in 2010 that was found earlier this year to contain incorrect data has now been retracted by Nature Medicine.
GlaxoSmithKline plc [LSE/NYSE: GSK] announced today the formation of the Oncology Clinical and Translational Consortium (OCTC)